Access

Access

Allocation of Bamlanivimab in U.S.

Neutralizing Antibody

Frequently Asked Questions

What is the process for ordering bamlanivimab?

What is the cost of the product and how will it be reimbursed?

How do I know if I have been approved to receive bamlanivimab?

Which sites of care will be eligible to accept and administer product?

I’ve been approved to receive bamlanivimab but I haven’t received product yet. What should I do?

Where can I find the most up-to-date information on where and how bamlanivimab is being allocated?

Genuine bamlanivimab

Safety Information

Limitations of Authorized Use

Important Safety Information

Hypersensitivity Including Anaphylaxis and Infusion-Related Reactions

Limitations of Benefit and Potential Risk in Patients with Severe COVID-19

Adverse Events

Use in Specific Populations